Insomnia Drug May Hold Promise for Alzheimer’s Prevention
Washington University School of Medicine researchers discovered an FDA-approved sleeping pill affects the levels of proteins that are critical for driving Alzheimer’s disease.
Read More
Author: Alyx Arnett
FDA Grants De Novo Status for Wearable System to Treat RLS
The prescription therapy is intended to treat symptoms of moderate to severe restless legs syndrome and improve sleep quality in patients refractory to medications.
Read More
AAO-HNS Recommends Nasal Valve Repair to Improve Obstruction Symptoms
Failure to perform nasal valve repair, when indicated, is a common cause of incomplete symptom resolution for patients with nasal obstruction and nasal valve dysfunction, according to the academy’s new position statement.
Read More
ProSomnus Publishes Four Abstracts on Oral Appliance Therapy
The data will be presented in oral and poster presentations at the 2023 American Academy of Dental Sleep Medicine Annual Meeting, being held from May 19 to 21 in Philadelphia.
Read More
Sleep Disturbance Likely Drives Breathlessness in Post-COVID Patients
Disturbed sleep patterns in COVID-19 patients hospitalized in the UK were found to be a driver of breathlessness, highlighting the potential for interventions targeting poor sleep quality to manage symptoms and convalescence following COVID-19 hospitalization.
Read More